Advised Teva on selling a pharmaceutical plant in Yaroslavl Industrial Park (Novosyolki) to R-Pharm Group (Russian high-tech pharmaceutical company, one of the largest pharmaceutical companies in Russia). The GMP-certified enterprise located on 19 hectares offers 13,000 sq.m. of production space. It manufactures medications for cardiological, neurological and endocrinological diseases. The terms of the sale transaction include a five-year agreement under which R-Pharm will act as Teva’s production partner in order to ensure continuous access for patients to Teva medicines. The sale of the plant is part of the company's global strategy to optimize production capacity.
Advised on the biggest ever office lease on the Moscow commercial real estate market: drafting and negotiating the future property lease for the office space in the building located in the centre of Moscow to accommodate Tinkoff’s headquarters, including all its core subdivisions, such as Tinkoff Bank, Tinkoff Insurance, Tinkoff Mobile, Tinkoff Development Center, etc.